NCT03144206View on ClinicalTrials.gov

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

PHASE4RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 19, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

SarcomaHyperbaric Oxygen Therapy

Interventions

DRUG

Hyperbaric oxygen

Patients with soft tissue sarcomas will receive HBOT treatment in the immediate postoperative period

Trial Locations (1)

273710

RECRUITING

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT03144206 - Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study | Biotech Hunter | Biotech Hunter